To assess the impact of left ventricular (LV) filling parameters on outcomes following trans-catheter aortic valve replacement (TAVR).
Introduction
The only treatment that improves survival and quality of life in patients with severe symptomatic aortic stenosis (AS) is valve replacement. 1 Over the past decade, trans-catheter aortic valve replacement (TAVR) has emerged as a less invasive option to surgical valve replacement. 2, 3 However, clinical experience demonstrates that some patients die soon after the procedure 4 -6 or continue to have heart failure and significant functional limitation. 3 In light of these observations, TAVR is often not offered to patients for whom valve replacement is thought unlikely to improve survival or symptoms. 3, 4 Some studies looking at predictors of survival have focused on clinical and demographic parameters. 4, 7 Others have reported that a low stroke volume index (SVI) or a low trans-valvular gradient prior to the procedure is associated with increased mortality following TAVR. 8 The objectives of this study were to examine the impact of preprocedural left ventricular (LV) filling parameters on mortality and heart failure following TAVR and the impact of TAVR on LV filling pressure.
Methods

Study design
From March 2009 through June 2014, 559 consecutive patients with severe symptomatic native AS [aortic valve area (AVA) ,1 cm 2 ] underwent TAVR at our hospital and were included in our ongoing single-centre prospective registry of TAVR. All patients were considered high risk for valve surgery by our institutional heart team. Clinical, echocardiographic, and procedural details for TAVR were prospectively recorded for all patients at baseline, 1-month, 6-month, and yearly clinical assessments. We excluded patients who had incomplete preprocedural Doppler echocardiographic data leaving 526 TAVR patients (94%) who were included in the study. Patients with other valvular diseases, including severe mitral calcification resulting in stenosis, were included in the study. For the same time period, we identified 300 consecutive patients with severe symptomatic native AS (AVA ,1 cm 2 ) who were treated conservatively at our hospital. Sixty-three of these patients (21%) had deceleration time (DT) ,160 ms and were included in our control short DT group. The reasons for not performing TAVR in these 63 patients included the following: 13 (21%) were considered too frail, 13 (21%) had unfavourable anatomic features for TAVR (5 with bicuspid aortic valve, 8 with severe sub aortic obstruction), 5 (8%) had cancer, and 32 (50%) refused TAVR. The study protocol was performed in accordance with the institutional ethics committees at Tel Aviv Medical Center, and all patients gave informed written consent for the procedures.
Baseline, follow-up, and clinical outcomes
Baseline clinical data were collected from patients and their medical files. Follow-up was also obtained from patient interviews and review of medical records. The primary end point was all-cause mortality. Secondary end points were (1) combined cardiac death and heart failure admission, and (2) cardiac death, heart failure admission, and new onset atrial fibrillation.
Echocardiography
Baseline echocardiography was performed in all patients. Patients who underwent TAVR had follow-up echocardiograms at 1-month and 6-month post procedure. Echocardiography was performed in a standard manner using the same equipment for each examination (iE33, Philips Medical Systems, Bothell, WA). Pulsed-wave (PW) Doppler in the apical four-chamber view was used to obtain mitral inflow velocities and assess LV filling patterns. A 1 -3 mm sample volume was placed between the mitral leaflet tips during diastole to record a crisp velocity profile after optimizing spectral gain and wall filter settings and setting sweep speeds of 100 mm/s. Measurements of mitral inflow included the peak early filling (E-wave) and late diastolic filling (A-wave) velocities, the E/A ratio, and DT of early filling velocity. Early diastolic mitral annular velocity (e ′ ) was measured in the apical four-chamber view.
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The e ′ was measured at the septal and lateral annulus in all patients including the patients with severe mitral annulus calcification. The ratio of peak E to peak e ′ (septal, lateral, and average) was calculated (mitral E/e ′ ratio). All the measurements were made at end expiration and averaged over 3 consecutive cardiac cycles in patients with sinus rhythm and 7 -10 cycles in patients with atrial fibrillation. 9, 10 Left atrial (LA) volume was calculated using the biplane area length method at end systole. Ejection fraction was calculated by Simpson's method. 11 LV diameter, inter-ventricular septal and posterior wall width, LV mass, and relative wall thickness were measured as recommended. Severe AS was defined by an AVA, as calculated by the standard continuity equation, of ,1.0 cm 2 . Forward stroke volume was calculated from LV outflow tract with subsequent calculation of cardiac output and index. Haemodynamic assessment included peak and mean trans-aortic gradient, tricuspid regurgitant velocity, and estimated right atrial pressure using the inferior vena cava to calculate the systolic pulmonary artery pressure. Mitral and aortic regurgitations were assessed by standard qualitative integrated approach according to the guidelines of the American Society of Echo (normal/trivial ¼ 1, mild ¼ 2, moderate ¼ 3, severe ¼ 4).
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The patients were separated into 3 groups according to the DT at baseline (before TAVR) based on recent guidelines 10 We sought to determine whether short DT has an impact on survival and event rate irrespective of SVI. We also separated patients into 4 groups according to their SVI and DT: (1) normal flow (SVI . 35 mL/m 2 ) and nonrestrictive filling pattern (≥160 m) (NF-NRF); (2) normal flow and short DT (,160 ms) (NF-SD); (3) low flow (SVI ,35 mL/m 2 ) and nonrestrictive filling pattern (≥160 m) (LF-NRF), and (4) low flow and short DT (LF-SD).
Inter-and intra-observer variabilities
Inter-observer variability for E wave velocity, A wave velocity, and DT was determined by a second independent blinded observer who measured the echocardiographic variables in 10 randomly selected patients. Intra-observer variability for the same parameters was determined by having the first observer who measured the data in all patients re-measure the parameters in the same patient at least 1 month apart.
Inter-and intra-observer variabilities were assessed using the BlandAltman method and the within-subject coefficient of variation. The within-subject coefficient of variation (calculated as the ratio of the standard deviation of the measurement difference to the mean value of all measurements) provides a scale-free, unit-less estimate of variation expressed as a percentage. Values of P , 0.05 were considered statistically significant.
Statistical analysis
Continuous normally distributed parameters were presented as means + SD and compared using Student's t-test. Ordinal and/or nonnormally distributed data were presented by median, first, and third quartiles and compared using the Wilcoxon rank sum test. Categorical data were compared between groups using the x 2 test or Fisher's exact test. In patients with TAVR, LV filling parameters were evaluated at baseline (before the procedure) and 1-and 6-month post TAVR. To avoid bias incurred by multiple comparisons, we used the repeated measures linear model analysis to define the within-group (with or without DT , 160 ms) effect for each parameter over time (for the entire cohort and for each group by itself), the between-group differences over time, and the group-by-time interactions. Clinical end points were death and cardiac event (death or heart failure readmission). Cox proportional hazards models for the end points allowed calculation of hazard ratios (HRs) attached to routine echocardiographic and LV filling parameters and were used unadjusted and adjusted. The covariates for the comprehensive multivariate survival analysis included SVI, age, gender, ejection fraction, chronic obstructive pulmonary disease (COPD), frailty, and creatinine. They were chosen based on either statistical impact on outcome (P , 0.05) in univariate analysis (SVI, age, gender, frailty, creatinine, COPD) or being traditional parameters in multivariate survival analyses (ejection fraction). Incremental value of DT vs. other LV filling parameters or vs. SVI for assessment of time to clinical end points were tested by comparing nested models with F-tests. Event distributions were calculated according to the Kaplan -Meier method and compared by means of the log-rank test. All P-values were two sided, and values of ,0.05 were considered to indicate statistical significance. All data were analysed with the JMP System software version 9.0 (SAS Institute, Inc., Cary, NC). All authors participated in designing the study, collecting and analysing data, and drafting and revising the manuscript. 
Results
Inter-and intra-observer variabilities
Comparison of intra-observer parameters showed good agreement between measurements: E wave velocity (mean difference 20.01 + 0.02 m/s; r ¼ 0.97; P ¼ 0.65), A wave velocity (mean difference 20.02 + 0.02 m/s; r ¼ 0.99; P ¼ 0.1), and DT (mean difference 12.4 + 14 ms; r ¼ 0.95; P ¼ 0.4). The Bland -Altman plot showed a random scatter of points around 0, indicating no systematic bias or measurement error proportional to the measurement value. Measurement variability (within-subject coefficient of variation) for measurements for intra-observer differences was as follows: E wave velocity 2.5%, A wave velocity 1.1%, and DT 7.2%.
Comparison of inter-observer parameters showed good agreement between measurements: E wave velocity (mean difference 20.04 + 0.03 m/s; r ¼ 0.97; P ¼ 0.2), A wave velocity (mean difference 20.05 + 0.03 m/s; r ¼ 0.98; P ¼ 0.1), and DT (mean difference 9.2 + 19 ms; r ¼ 0.99; P ¼ 0.1). The Bland -Altman plot showed a random scatter of points around 0, indicating no systematic bias or measurement error proportional to the measurement value. Measurement variability (within-subject coefficient of variation) for measurements for intra-observer differences was as follows: E wave velocity 3.8%, A wave velocity 3.1%, and DT 1.7%. Survival after TAVR 
Cardiac events after TAVR
There were 172 combined cardiac events (115 deaths, 52 episodes of new onset atrial fibrillation, and 82 admissions for heart failure) during follow-up ( Table 2) . LV filling parameters and other echocardiographic parameters associated with rate of cardiac events are shown in Table 2 .
Deceleration time groups
Although A wave velocity, LA volume, and high E/A ratio were all associated with worse clinical outcome, the addition of DT in nested models eliminated all these parameters and improved model prediction (P , 0.05 for all analyses) so that all subsequent analyses focused on DT rather than other LV filling parameters. Table 3 shows baseline clinical and echocardiographic characteristics of the TAVR patients stratified by the DT group. Table 2 and Figure 1 show the effects of DT on survival ( Figure 1A ) and cardiac events ( Figure 1B) .
DT , 160 ms was significantly associated with cardiovascular death, HR 3.1 (1.3 -7.0); P ¼ 0.01, and death of unknown cause, HR 2.8 (1.4 -5.2); P ¼ 0.001, but not with non-cardiac death, HR 0.81 (0.32-1.8); P ¼ 0.5.
DT , 160 ms was significantly associated with combined death and heart failure, HR 1.6 (1.18-2.3); P ¼ 0.004.
Intermediate (pseudo-normal) DT and prolonged (delayed relaxation type) DT showed no association with survival or combined death heart failure after TAVR (P ¼ 0.2 for both). However, short (restrictive) DT was associated with lower survival and freedom from event rate, than in patients with prolonged (46 + 7 vs. 73 + 4% at 3 years, P ¼ 0.002; 38 + 6 vs. 60 + 5% at 3 years, P ¼ 0.001, respectively) or intermediate DT (46 + 7 vs. 72 + 4% at 3 years, P ¼ 0.05; 38 + 6 vs. 51 + 6% at 3 years, P ¼ 0.04, respectively). When we separated the groups by DT . 258 ms, the results were similar. Intermediate (pseudo-normal) DT and prolonged (delayed relaxation type) DT showed no association with survival or combined death heart failure after TAVR (P ¼ 0.2 for both). However, short (restrictive) DT was associated with lower survival and freedom from event rate, than in patients with DT . 258 ms (46 + 7 vs. 72 + 6% at 3 years, P ¼ 0.002; 38 + 6 vs. 57 + 6% at 3 years, P ¼ 0.002, respectively) or intermediate DT (46 + 7 vs. 72 + 4% at 3 years, P ¼ 0.05; 38 + 6 vs. 53 + 5% at 3 years, P ¼ 0.03, respectively).
The Kaplan -Meier survival curves ( Figure 1A and B) show considerable survival and cardiac event rate difference after diagnosis between short and longer DTs.
Mitral annulus calcification
Mitral annular calcification (MAC) has the potential to affect LV filling parameters by increasing E wave or prolonging the DT. We have performed the entire set of analyses including only the 233 patients with no MAC (Supplementary data online, Tables S1 -S4 
Subgroup and multivariable analysis
DT is usually shorter for patients with atrial fibrillation. Because the strong association of DT with prognosis may have been related to the presence of atrial fibrillation, we assessed the impact of DT on survival in patients with sinus rhythm and atrial fibrillation separately. Analyses demonstrated low survival with short DT irrespective of rhythm at baseline (P ¼ 0.03; P ¼ 0.05 for sinus or atrial fibrillation, respectively). Multivariable analysis stratified by baseline rhythm showed that short DT is independently associated with lower survival in sinus rhythm [1.6 (1.00, 2.5); P ¼ 0.05] and atrial fibrillation [1.8 (0.92, 4.3); P ¼ 0.07]. Cox proportional hazard analysis with interaction terms for DT (,160 ms or ≥160 ms) and baseline rhythm (sinus or atrial fibrillation) showed that baseline rhythm does not affect the impact of short DT on survival (P ¼ 0.6). Importantly, because the stronger association of DT with prognosis compared with E/e ′ may have been biased by the presence (or the absence) of atrial fibrillation, we have assessed the impact of LV filling parameters in patients with sinus rhythm and atrial fibrillation separately. Analyses have demonstrated similarly lower survival (P ¼ 0.03; P ¼ 0.05 for sinus or atrial fibrillation, respectively) with short DT irrespective of rhythm at baseline. Nevertheless, although in the entire cohort, and in patients with sinus rhythm E/e ′ septal, E/e ′ lateral, and E/e ′ average were not associated with mortality, and DT was the strongest diastolic parameter, in the patients with atrial fibrillation, all types of E/e ′ ratio were strongly associated with 
2).
New pacemakers were implanted in 116 (22%) of patients. Pacemaker implantation post TAVR was much more common in the core valve group (Core-valve group 25.5% vs. Edwards 12.0%; P ¼ 0.0007). Because pacemaker implantation may impact on the quantification of LV filling parameters, we separated the patients into two groups, those with pacemaker after TAVR, or no pacemaker, and assessed the impact of DT in the groups separately. Analyses have demonstrated that higher mortality with short DT was solely in patients with pacemakers [HR 2.1 (1.16-4.09); P ¼ 0.01], but not in patients without pacemaker [HR 1.59 (0.89 -2.69); P ¼ 0.1]. Nevertheless, Cox proportional hazard analysis with interaction terms for DT (, or ≥160 ms) and the presence or the absence of pacemaker showed that the interaction term did not reach statistical significance (P ¼ 0.5).
Recent study reported that the presence of low flow (SVI , 35 cc/m 2 ) 8 is associated with increased mortality following TAVR.
Supplementary data online, Table S6 shows baseline clinical and echocardiographic characteristics of the TAVR patients stratified by SVI and DT. All-cause mortality was significantly higher in LF-SD compared with all other groups (52 + 9% in LF-SD, 82 + 3% NF-NRF, 67 + 8% NF-SD, and 70 + 5% LF-NRF; P , 0.05 for all comparisons). Freedom from cardiac events was lower in the LF-SD compared with all other groups (37 + 8% in LF-SD, 72 + 3% NF-NRF, 52 + 8% NF-SD, and 66 + 5% LF-NRF; P , 0.05 for all comparisons) but not between other groups. Addition of DT groups to the analyses showed that DT , 160 ms was independently associated with lower survival and higher rate of cardiac events, even after adjustment for age, gender, SVI, and co-morbidities (Table 4) , with improved predictive power for all models (P , 0.05 for each). Moderate or more mitral regurgitation was observed in 21% of the patients and has the potential to affect the inflow pattern. We analyzed the influence of severity of MR on inflow pattern parameters (Supplementary data online, Table S5 ). All inflow parameters were influenced by MR including E wave, A wave, their ratio, DT, and all E/e ′ ratios. Nevertheless, Cox proportional hazard analysis with interaction terms for DT (, or ≥160 ms) and severity of MR (≥ or , than moderate) showed that the interaction term did not reach statistical significance (P ¼ 0.6).
Effects of TAVR on haemodynamics in patients with restrictive physiology
The time courses of changes in E/A ratio, DT, and SPAP in patients with short or long DT are shown in Figure 2A -C and Supplementary data online, Table S7 . In patients with baseline DT ≥ 160 ms, DT did not change between baseline, 1-month, and 6-month post TAVR, while there was a significant increase in DT in the short DT group (P , 0.0001). DT lengthening was greater in the short DT group vs. the long DT group (P , 0.0001 for time x group interaction). Similarly, for patients with long DT, E/A ratio showed no significant change between baseline, 1-month, and 6-month post TAVR echocardiograms, while there was a significant decrease in E/A ratio in the short DT group (P ¼ 0.05). E/A ratio decline was greater in the short DT group vs. the long DT group (P ¼ 0.002 for time x group interaction). Finally, in patients with long DT, SPAP showed no significant change between baseline, 1-month, and 6-month post-TAVR echocardiograms, while there was a significant decrease in SPAP in the short DT group (P , 0.0001). SPAP decline was greater in the short DT group vs. the long DT group (P ¼ 0.0007 for time x group interaction). To assess whether improvement in DT impacted survival in patients post TAVR, we compared outcomes in patients with short DT (,160 ms) who improved at 1 month (to DT ≥ 160 ms) with outcomes in patients with short DT with no improvement at 1 month. Patients with short baseline DT that normalized at 1 month had comparable outcomes with patients with DT ≥ 160 ms at baseline (73 + 7 vs. 78 + 3% at 2 years, P ¼ NS). However, outcomes for patients with persistent short DT at 1-month post TAVR were bleak (44 + 12%, P ¼ 0.004 compared with other groups).
Effects of TAVR on outcome in patients with restrictive physiology similar patients treated conservatively (N ¼ 63). Supplementary data online, Table S8 shows baseline clinical and echocardiographic characteristics of the patients with restrictive physiology (DT , 160 ms) stratified by treatment (TAVR vs. conservative). The conservatively treated patients were similar to the TAVR patients in all the echocardiographic parameters, had less advanced heart failure, but greater frailty. Univariate analysis stratified by DT time showed improved survival post TAVR compared with conservative treatment in among patients with short DT [HR 1.6 (1.01, 2.65); P ¼ 0.05], similar to that seen in patients with longer DT [1.9 (1.34, 2.62); P ¼ 0.0003]. Cox proportional hazard analysis with interaction terms for DT (, or ≥160 ms) and treatment assignment (conservative vs. TAVR) showed that the presence or the absence of restrictive physiology did not affect the positive impact of TAVR on survival in patients with severe AS (P ¼ 0.6). TAVR was associated with better survival compared with conservative treatment, in patients with short DT (62 + 7 vs. 53 + 8% at 2 years, P ¼ 0.05; Figure 3) . This difference remained significant on multivariable analysis adjusted for age, gender, and SVI [HR 1.6 (1.01-2.7); P ¼ 0.05].
Discussion
The main findings of our study are as follows: (1) LV filling parameters associated with increased filling pressure (reduced A wave velocity, short DT, large LA volume) are associated with poor longterm outcomes post TAVR; (2) DT is superior to all other LV filling parameters in predicting clinical outcomes post TAVR in the entire cohort, but E/e ′ average is superior in patients with atrial fibrillation; (3) restrictive physiology (DT , 160 ms) is an independent predictor of outcome; (4) assessment of LV filling parameters, and DT in particular, helps to identify patients at high risk of post-TAVR complications and should be included in pre-TAVR risk stratification; and (5) LV filling parameters improve in most patients after TAVR, and TAVR is associated with better outcomes than conservative therapy even in patients with restrictive physiology. Thus, restrictive physiology should not be considered an impediment to performance of TAVR.
LV filling parameters, deceleration time, and outcome after TAVR Numerous studies have reported that LV filling parameters are powerful independent risk factors for the presence of symptoms in patients with severe AS and increased mortality following surgical aortic valve replacement. 13 -17 Although several studies have dealt with effects of TAVR on diastolic dysfunction, 18 -20 the impact of pre-TAVR abnormal LV filling parameters on long-term outcome is unknown. We found DT to be superior to all other LV filling parameters for predicting outcome in the entire cohort, but E/e ′ average to be the best parameter in patients with atrial fibrillation. Mitral DT is an important parameter for assessing LV stiffness. 21, 22 Because of a relatively constant LA pressure during early LV filling, DT is proportional to the inverse square root of LV stiffness. Our results are compatible with previous findings 13 that showed DT to be a significant predictor of outcome in elderly patients after aortic valve replacement for severe AS. LV filling parameters such as E wave velocity, e ′ (septal, lateral, or average), and their ratios were not predictive of outcome in patients post TAVR apart from patients with atrial fibrillation and a trend in patients without mitral annulus calcification. These results are at odds with previous reports that reported E/e ′ was significantly correlated with LV end diastolic pressure in patients with severe AS, 23 and is the most important predictor of outcome after surgical aortic valve replacement. 24 This inconsistency may be explained by differences in the cohorts In patients with baseline DT ≥ 160 ms, E/A ratio, DT, and SPAP did not change between baseline, 1-month, and 6-month post TAVR. However, patients with short DT at baseline showed a significant decrease in E/A ratio (P ¼ 0.05), increase in DT (P , 0.0001), and decrease in SPAP (P , 0.0001). The groups x time interactions were significant for all comparisons, suggesting that although patients with restrictive physiology at baseline are sicker and have inferior prognosis, they are also the patients that benefit most from a successful procedure.
studied. 24 Our patients were older than the historic surgical cohorts, typical for TAVR patients, with significant mitral annulus calcification in the majority of patients. Old age and severe mitral annulus calcification limit the assessment of mitral inflow and annular velocities, and the E/é ratio may not provide a reliable estimate of filling pressures.
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Diastolic dysfunction, forward flow, preload, mitral disease, and outcome after TAVR
In the present study, short DT and to a lesser extent increased E/A ratio were associated with poor outcomes after adjustment for other known risk factors including SVI. Although reduced SVI was independently associated with increased early and late mortalities, echocardiographic signs of restrictive physiology added significant prognostic value to the predictive models. In fact, the combination of low stroke volume and restrictive physiology predicted worse outcomes than either one alone. While SVI is a direct measure of pump function, it is dependent on LV end diastolic pressure through the Frank -Starling mechanism. Patients with low SVI and long DT often have low LV filling pressure and good pump function and may be expected to improve with optimization of volume status.
On the other hand, low stroke volume associated with restrictive physiology denotes elevated LV wall stress, associated with increased fibrosis, lack of contractile reserve, 25 and predicts poor outcome after aortic valve replacement. 13 -15 Dopplerechocardiography-derived mitral inflow indices are influenced by different physiological variables that include severity of annular calcification, mitral regurgitation (Supplementary data online, Tables S1 -S5), or any other variable that influences preload and filling pressure, and not just 'diastolic function' (LV relaxation and compliance). Nevertheless, irrespective of mechanism, DT was superior to all other LV filling parameters in predicting mortality or other cardiac events.
Effects of TAVR on haemodynamics and outcome in patients with restrictive physiology
Though patients with restrictive physiology pre-TAVR have lower survival, these patients gain benefit from the procedure as LV filling parameters (DT and E/A), and haemodynamics (SPAP) improve to a greater extent post procedure when compared with other patients. Our data reinforce the results presented by others. 20 Further, though restrictive physiology predicts reduced survival post TAVR, the procedure still improves survival in these patients when compared with conservative therapy. Thus, we believe that restrictive physiology pre-TAVR should not be a contraindication to the procedure.
Study limitations
This was a single-centre, non-randomized, retrospective study, and there was no Core Laboratory for the analysis of echocardiograms. We did not exclude patients with low EF, low flow, or other conditions, such as mitral annulus calcification, that may alter LV filling measurements. Nevertheless, we found LV filling measures to be predictive of outcomes, particularly the DT. Because of the relatively small number of patients and events, we lacked the statistical power to show associations between DT and clinical end points in subgroups or to investigate possible interactions between DT, type of valve, or need for pacemaker post TAVR. Similarly, other potentially relevant associations may not have reached significance. Atrial fibrillation was more prevalent among patients with a restrictive filling pattern, which may have impaired measurement of LV filling parameters given the beat-to-beat variability. Doppler-echo estimation of SVI may be subject to measurement errors, particularly in the presence of poor image quality, elliptic shape of the LV outflow tract, or atrial fibrillation. Global longitudinal strain (GLS) is particularly suited for analysing LV function. However, we did not systematically evaluate GLS. We believe that the information contained in this manuscript should encourage consideration of imaging with GLS to assess the LV in patients with severe AS. 26 
Conclusions
Echocardiographic assessment of LV filling parameters pre-TAVR is predictive of clinical outcomes after the procedure, with a short DT being the most powerful predictor of adverse outcomes apart from patients with atrial fibrillation in whom E/e ′ is the best predictor.
However, LV filling parameters improve in most patients after TAVR, including those with short DT, and TAVR is associated with better outcomes than conservative therapy, even when there is pre-existing restrictive filling.
Supplementary data
Supplementary data are available at European Journal of Echocardiography online.
